 |
 |

Effects of the Pulsed Electron Avalanche Knife on Retinal Tissue
Daniel. V. Palanker, PhD;
Michael F. Marmor, MD;
Andre Branco, MD;
Philip Huie, MSc;
Jason M. Miller, MSc;
Steven R. Sanislo, MD;
Alexander Vankov, PhD;
Mark S. Blumenkranz, MD
Arch Ophthalmol. 2002;120:636-640.
Objectives To evaluate the precision of retinal tissue dissection by the pulsed
electron avalanche knife (PEAK) and to assess possible toxic effects from
this device.
Methods To demonstrate precision of cutting, bovine retina (in vitro) and rabbit
retina (in vivo) were incised with the PEAK. Samples were examined by scanning
electron microscopy and histologic examination (light microscopy). To evaluate
possible toxic effects in rabbit eyes, 30 000 pulses were delivered into
the vitreous 1 cm above the retina. Histologic examinations and electroretinography
were performed at intervals up to 1 month after exposure.
Results Cuts in postmortem bovine retina showed extremely sharp edges with no
signs of thermal damage. Full-thickness cuts in living attached rabbit retina
were similarly sharp and were typically less than 100 µm wide. No signs
of retinal toxic effects were detected by histologic examination or electroretinography.
Conclusions The PEAK is capable of precise cutting through retinal tissue, and there
are no demonstrable retinal toxic effects from its use. The precision and
tractionless nature of PEAK cutting offers advantages over mechanical tools
and laser-based instrumentation. We believe this new device will prove useful
in a variety of vitreoretinal surgical applications.
From the Department of Ophthalmology, School of Medicine (Drs Palanker,
Marmor, Branco, Sanislo, and Blumenkranz and Messrs Huie and Miller) and W.
W. Hansen Experimental Physics Laboratory (Drs Palanker and Vankov), Stanford
University, Stanford, Calif. Stanford University is the owner of a patent
covering the use of the electric plasma-mediated cutter. Should the Stanford
University receive royalties or other financial remuneration in the future
related to the patent, Dr Palanker may receive a share in accordance with
the Stanford University Institutional Patent Policy and Procedures, which
include royalty-sharing provisions. Drs Palanker and Blumenkrantz are consultants
to Carl Zeiss, Inc, Jena, Germany.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pulsed electron avalanche knife: new technology for cataract surgery
Priglinger et al.
Br J Ophthalmol 2007;91:949-954.
ABSTRACT
| FULL TEXT
Gene transfer to rabbit retina with electron avalanche transfection.
Chalberg et al.
IOVS 2006;47:4083-4090.
ABSTRACT
| FULL TEXT
Pulsed Electron Avalanche Knife (PEAK-fc) for Dissection of Retinal Tissue
Priglinger et al.
Arch Ophthalmol 2005;123:1412-1418.
ABSTRACT
| FULL TEXT
Precision and Safety of the Pulsed Electron Avalanche Knife in Vitreoretinal Surgery
Miller et al.
Arch Ophthalmol 2003;121:871-877.
ABSTRACT
| FULL TEXT
|